News About: Pharm. Industry
Application for bio-equivalent test doubled in May.
The number of application for the bio-equivalent test in May rose rapidly amid which bio-equivalent test shall be obligated to submit for any generic product registration from the 2nd half of this year but the price ...
24 KSE-listed pharmaceutical firms post strong 1st-quarter earnings
The combined first-quarter turnover of the 24 major pharmaceutical firms closing fiscal year in December, which is listed in the Korea Stock Exchange, posted 813.6 billion won, up 9.32 percent compared with 744.2 bill...
Immunity gene therapeutic technologies predicted market dominance in 10 years.
A bio technology expert predicted that the immunity gene therapy would be recognized as a leading therapeutic technology in coming years, and so important that its provisional ground and infrastructure should be built...
Activation of OTC sales crucial to survival of domestic pharmaceutical industry
Despite local medical community's allegation that planned attempt to promote OTC sales by some pharmaceutical firms may encourage the illegal dispensing of pharmacists and impair the intrinsic treatment rights, there ...
Hanmi Pharm reports strong 1st-quarter results
Hanmi Pharm, which made new launchings of nefedipine (a generic version of Bayer's Adalat Oros with 25 billion won in sales) and Testogel (testosterone) for men in April, reported a strong performance for its fiscal f...
Industry on alert to government prosecution against hospital deals.
Drug makers are sharply alert to KFDA's measures against their direct hospital deals on one hand while keeping their rigid position against any measures if ever raised by the government on the other.
The industry...
Domestic pharmaceutical industry seeks technical cooperation in China
Senior officials from the Korea Pharmaceutical Manufacturers Association arrived in China on May 12 to discuss ways to enhance their technical cooperation and envisage market inroads to China showing an annual growth ...
Domestic pharmaceutical firms urged to nurture non-flagship products
Major domestic pharmaceutical firms have relied heavily on flagship products to achieve their sales target amid protracted business slump, but market analysts say that there is an urgent need to cultivate non-flagship...
Pfizer Korea launches Viagra V-life program
Pfizer Korea said it has started launching Viagra V-life program as part of its efforts to ensure confidence and satisfaction of sexual life in patients with erectile dysfunction (ED).
The V-life program, which is ...
Local study in patients with diabetes show significant improvement during Lipitor treatment
Pfizer's cholesterol drug Lipitor (atorvastatin calcium) showed better improvement in lowering the levels of low-density lipoprotein cholesterol (LDL-C), bad cholesterol that is primary responsible for the development...
